This video is featured in the 2024 ESMO Annual Meeting Insights Hub

ESMO 2024 Insights: Predicting the Outcomes of Advanced Cutaneous Melanoma Cases Following Discontinuation of Immune Checkpoint Inhibition

65 views
October 3, 2024
Comments 0
Login to view comments. Click here to Login